Biotronik introduces Solia CSP S pacing lead
Biotronik has announced the market release of Solia CSP S, a cardiac pacing lead designed specifically for conduction system pacing (CSP) procedures. The device represents the first pacing lead worldwide to combine a fixed screw design with stylet-driven implantation, according to the Berlin-based medical technology company.
First commercial implants completed in Spain
The initial global commercial implants were performed by Dr Óscar Cano at the University and Polytechnic La Fe Hospital of Valencia, Spain. “In my experience, the stylet-driven Solia CSP S together with the Selectra 3D catheter enabled good alignment with the septal wall and it was easy to penetrate the septum,” said Dr Cano. “The procedures went very fast, and we had only minimal use of fluoroscopy.”
Design features aim to simplify procedures
Solia CSP S incorporates a fixed screw design intended to reduce preparation time whilst maintaining the steerability advantages of stylet-driven systems. The device enables continuous electrical measurements during implantation procedures.
The lead features a newly developed screw designed to facilitate smoother septal tissue penetration, which the company states may help reduce the number of lead rotations required. The optimised distal end has been engineered to enhance durability and steerability, providing physicians with improved control during implantation. The simplified handling allows for single operator use and minimises preparation steps.
Addressing growing demand for physiologic pacing
“The launch of Solia CSP S represents a step forward in making CSP procedures more accessible and efficient,” said Andreas Hecker, President CRM/EP at Biotronik. “It is part of our ongoing commitment to physiologic pacing and providing physicians with tools that streamline implantation for better patient outcomes.”
Conduction system pacing is emerging as a new standard of care within cardiac device therapy. Dr Joaquín Osca Asensi, Head of the Arrhythmia Unit at La Fe Hospital of Valencia, Spain, noted: “The challenge in cardiac rhythm management today, is to treat more patients whilst maintaining the highest standards of care. Tools like Biotronik’s CSP solution help us deliver physiologic pacing whilst keeping workflows lean and manageable.”
Biotronik has been developing medical technology for over 60 years, focusing on cardiac rhythm management, monitoring, neuromodulation, and electrophysiology solutions. The company, headquartered in Berlin, operates across more than 100 countries in the Americas, EMEA, and Asia regions. Biotronik created Germany’s first pacemaker in 1963.
- For more information, visit: https://www.biotronik.com/en-us/products/solia-csp-s
